logo

Correvio Pharma Corp. (CORV)



Trade CORV now with
  Date
  Headline
3/30/2020 7:10:04 AM Correvio FY Loss Per Share $0.79 Vs Loss $0.47 Last Year
3/16/2020 7:15:06 AM ADVANZ PHARMA To Acquire All Issued And Outstanding Shares Of Correvio
3/10/2020 7:33:54 AM Correvio Pharma Teams With Hong Kong Teson Pharma Limited For Commercialization Of Aggrastat In China
1/28/2020 8:14:55 AM Correvio Receives NASDAQ Notification Regarding Deficiencies In Minimum Bid Price
12/24/2019 8:01:35 AM Correvio Receives Complete Response Letter From FDA For Brinavess
12/11/2019 8:09:26 AM Correvio Pharma Plans To Explore Strategic Alternatives
12/11/2019 8:02:47 AM Correvio Plans To Explore Strategic Options
12/10/2019 7:07:33 AM Correvio Announces FDA Advisory Committee Meeting To Discuss Brinavess For Recent Onset Atrial Fibrillation
11/14/2019 7:19:53 AM Correvio Q3 Net Loss $10.8 Mln Vs Net Loss $7.1 Mln Last Year
11/4/2019 7:15:00 AM Correvio Announces FDA Advisory Committee Meeting To Review Brinavess For Recent Onset Atrial Fibrillation
9/3/2019 8:03:28 AM Correvio Announces Presentation Of Brinavess® Spectrum Data
8/14/2019 7:13:30 AM Correvio Q2 Net Loss $10.5 Mln Or $0.26/Shr Vs Net Income $5.4 Mln Or $0.16/Shr Prior Year
8/14/2019 7:12:03 AM Correvio Q2 Net Loss $10.5 Mln Or $0.26/Shr Vs Income Of $5.4 Mln Or $0.16/Shr Last Year
8/7/2019 9:28:54 AM Correvio Closes Public Offering Of 9.20 Mln Common Shares
  
 
>